S
Silke Raats
Researcher at University of Antwerp
Publications - 2
Citations - 2
Silke Raats is an academic researcher from University of Antwerp. The author has contributed to research in topics: Vaccination & Cancer. The author has an hindex of 1, co-authored 1 publications receiving 1 citations.
Papers
More filters
Journal ArticleDOI
Antibody Response after BNT162B2 COVID-19 mRNA Vaccination in Cancer Patients Under Anti-Neoplastic Treatment
Marc Peeters,Lise Verbruggen,Laure-Anne Teuwen,Greetje Vanhoutte,Sara Vande Kerckhove,Bart Peeters,Silke Raats,Isolde Van der Massen,Sven De Keersmaecker,Manon T. Huizing,Pieter Pannus,Kristof Y. Neven,Kevin K. Ariën,Geert A. Martens,Marc Van Den Bulcke,Ella Roelant,Isabelle Desombere,Sébastien Anguille,Maria E Goossens,Timon Vandamme,Peter van Dam +20 more
TL;DR: The BNT162b2 COVID-19 vaccine is well-tolerated in cancer patients under active treatment, however, the antibody response of immunized cancer patients was delayed and diminished, mainly in patients receiving chemotherapy or rituximab, resulting in breakthrough infections.
Journal ArticleDOI
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors
Angelina Konnova,Fien H. R. De Winter,Lisanne C Verbruggen,An Hotterbeekx,M. Berkell,Laure Anne Teuwen,Greetje Vanhoutte,B. Peeters,Silke Raats,Isolde Van der Massen,Sven De Keersmaecker,Y. Debie,M. T. Huizing,Pieter Pannus,Kristof Y. Neven,K. K. ArieÌn,Geert A. Martens,Marc Van den Bulcke,Ella Roelant,Isabelle Desombere,Sébastien Anguille,Zwi N. Berneman,M. Goossens,Herman Goossens,Surbhi Malhotra-Kumar,E. Taconelli,Timon Vandamme,Marc Peeters,P. V. van Dam,Samir Kumar-Singh +29 more
TL;DR: In this article , the authors employed machine learning approaches to identify a biomarker signature based on blood cytokines, chemokines, and immune-and non-immune-related growth factors linked to vaccine immunogenicity in 199 cancer patients receiving the BNT162b2 vaccine.